Juravinski Cancer Center

Hamilton, Ontario LbV 5C2

1 studies enrolling now · 15 studies all time

What they study most

Acute Myelogenous Leukemia, Androgen-Resistant Prostatic Neoplasms, Bladder Cancer, CANCER,NOS, Cancer, Carcinoma, Squamous Cell of the Head and Neck, Castration Resistant Prostatic Neoplasms, Complete Response, Epithelial Ovarian Cancer, FIGO Stage III-IV, Fallopian Tube Cancer, Head and Neck Cancer

Studies at this site

• A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis — Recruiting now
• Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer — Completed
• A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy — Running, not enrolling
• A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors) — Completed
• Phase 3 Study to Treat Patients With Soft Tissue Sarcomas — Completed
• A Study of an Anti-KIR Antibody Lirilumab in Combination With an Anti-PD1 Antibody Nivolumab and Nivolumab Plus an Anti-CTLA-4 Ipilimumab Antibody in Patients With Advanced Solid Tumors — Completed
• Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors — Running, not enrolling
• A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma — Completed
• A Study of IMGN901 for Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer — Stopped early
• Safety and Tolerability Study of SOR-C13 in Subjects With Advanced Cancers Commonly Known to Express the TRPV6 Channel — Completed
• Safety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder Cancer — Completed
• Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START) — Completed
• Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers — Completed
• A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I) — Completed
• Safety and Efficacy of RK0202 in Oral Mucositis — Completed